Therapeutic Effect of the Natural Mineral Water of the Well B-308 OKK in Győr (Gyirmót) on Knee Osteoarthrosis

Launched by UNIVERSITY OF PECS · May 16, 2024

Keywords

ClinConnect Summary

After being informed about the study and the potential risks, all patients giving written informed consent will undergo a continuous screening period, until the number of 25-25 patients is reached, to determine eligibility for study entry. At week 0, patients who meet the eligibility requirements will be randomized in a double-blind manner in a 1:1 ratio to medicinal water or placebo group.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Knee osteoarthrosis that has existed for at least 3 months
• • Age between 50 and 80 years
• • Willingness to participate in 3-week outpatient rehabilitation treatment
• • Pain in the knee joint lasting at least 3 months and at least 5 days a week
• • At least mild pain during selection (1 point on the Likert scale)
• • Does not have a serious disability
• Exclusion Criteria:
• • Any kind of physiotherapy treatment in the last 2 months (except home gymnastics)
• • Any previous knee joint surgery
• • Any trauma to the knee or hip joint in the 1 year prior to the examination
• • Knee arthroscopy performed within 3 months prior to the examination
• • Intra-articular corticosteroid treatment of the affected knee in the last 3 months
• • Palpable Baker's cyst
• • Any hip joint or spine surgery within a year before the examination
• • Intra-articular hyaluronic injection within 2 months before the examination
• • Appearance of lumbar radiculopathy
• • Presence of serious internal medicine disease, urogenital or other diseases
• • Uncooperative or psychoneurotic patients
• • Lumbago, sciatica; and any other surgery or previous fracture in the hip joint
• • Subluxation, luxation, algodystrophy, fibromyalgia, gout
• • Balneotherapy in the last 6 months
• • Systemic corticosteroid treatment in 1 month before the examination
• • Starting the treatment of osteoarthritis SYSADOA (symptomatic slow-acting drugs for osteoarthritis) in 3 months before the examination

Trial Officials